Winter’s Capital has taken a unique approach when it comes to biotechnology. Traditionally we stay away from pharmaceutical investments and focus on proprietary (preferably patentable) natural technologies. To date, our portfolio contains a variety of patented or patent pending dietary supplement formulations. We believe as dietary supplements keep expanding rapidly the consumer will be driven towards ingredients that are well researched and standardized.
Pharmaceuticals will always have a place, however, dietary supplements offer tremendous growth year over year. Plus, as popularity grows and legislation increases, we feel the proprietary and standardized ingredient sector is a great place to be.